Randomised, controlled, single-blinded pilot study to assess the efficacy of psychodynamic art therapy in a sample of hospitalized, (sub)acutely psychotic patients with a diagnosis of schizophrenia compared to a group of patients receiving treatment as usual. \*Main hypothesis: Art therapy has no impact on clinical symptoms and the course of remission compared to TAU. \*Exploratory hypotheses: Art therapy has no influence on quality of life, mentalizing function, self-efficacy and neuroleptic dosage compared to TAU.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
60
2 sessions à 1.5 hrs /week, intervention duration 6 weeks
Psychiatrische Universitätsklinik der Charité im St. Hedwig Krankenhaus
Berlin, Germany
Change in Positive and Negative Syndrome Scale (PANSS-) scores
assessment of change of schizophrenic positive, negative and general symptom scores
Time frame: weeks 0, 6, 12
safety measures
number of participants with adverse events
Time frame: weeks 0, 6, 12
Change in Calgary depression Scale (CDS-) scores
assessment of change of depressive symptoms in schizophrenic patients as reflected by CDS-scores
Time frame: weeks 0, 6, 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.